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Abstract
In this study, we prepared hydroxyapatite (HAP) samples using hydrothermal method. We investigated the effect of reaction conditions 
such as phosphate excess applying 1.49 and 1.67 (as stoichiometric) Ca/P ratio, pH (9/ 10/ 11/ 12) and time (4/ 8/ 12/ 24 h). Sample 
characterization was carried out by XRD and SEM. The results showed, all samples had HAP structure, however, lower Ca/P ratio, 
larger reaction time and setting the pH to 10 increased the crystallinity. Then, we synthetized Sr-doped HAP samples, varying the Sr 
concentration using 2, 4, 6, 8 and 10 % Sr/ (Ca+Sr). The Sr content was revealed by EDX. Sr-incorporation did not change the obtained 
crystalline HAP phase but the unit cell parameters increased. We calculated lattice constants and found that a, b changed from 9.4310 Å 
to 9.4700 Å, c from 6.8819 Å to 6.9227 Å and the unit cell volume from 530.0951 Å3 to 537.6556 Å3 due to the larger ionic radius of Sr 
compared to Ca. The pure and doped samples had uniform, mostly needle-like morphology with 100-300 nm length and 25-100 nm. 
In vitro cytotoxicity tests revealed evident antibacterial activity in the case of doped samples compared to pure HAP against E. coli.
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1 Introduction
Hydroxyapatite (HAP, Ca10(PO4)6OH2) has become one 
of the most investigated biomaterials over the past few 
decades due to its excellent biocompatibility and bonding 
ability to natural tissues. In nature it can be found among 
the components of hard tissues such as bone, enamel and 
dentine. In its natural form the molar ratio of Ca/ P is less 
than the stoichiometric 1.67 due to the presence of sig-
nificant amounts of CO3
2-, HPO42-, Na+ and Mg2+ ions and 
various trace elements such as Sr2+, Zn2+, Fe2+, F- [1–7]. 
Since the chemical formula and physico-chemical prop-
erties of the synthetic HAP are so similar to those in the 
living tissues, it is suitable for many medical applications. 
It can be used for bone regeneration and substitution as 
bone filler, scaffold or implant coating, moreover, it has 
promising results in drug delivery and releasing systems 
as well [1, 8, 9].
For promoting its possible applicability in living body, 
its rejection after implantation should be avoided. To facil-
itate its integration, synthetic HAP not only has to be 
biocompatible but should also exhibit antibacterial prop-
erties for inhibition of bacterial infections. The develop-
ment of these characteristics is of great interest and can be 
achieved by composite formation, loading with drugs or 
organic components, and metal ion doping [10–13]. 
During metal ion incorporations mainly Ca2+ is 
replaced by Mg2+, Zn2+, Sr2+ and Ag+. With the usage of Ag 
the antibacterial activity and non-cytotoxicity increase 
significantly [9, 14, 15], Mg, Zn and Sr can induce greater 
osteoconductivity, cytotoxibility or even antimicrobial 
effect, but Sr can also promote sustained drug release [13, 
16–23]. The replacement of Ca2+ by another ion modifies 
the crystal structure by causing unit cell contraction or 
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expansion depending on the ionic radii, but also has influ-
ence on the crystallinity, crystallite size, morphology, 
surface charge and solubility.
In this study, we prepared pure and Sr-doped HAPs by 
a simple one-step hydrothermal method. We investigated 
the effect of Ca/P ratio fixing it at two various values (1.49, 
1.67), studied the role of reaction time (4/ 8/ 12/ 24 h) and 
solution pH (9/ 10/ 11/ 12) on the crystalline structure and 
morphology of the as-prepared samples. For Sr doping we 
applied different Sr/ (Ca+Sr) molar ratios namely (2/ 4/ 6/ 
8/ 10 %). We analyzed the crystalline phases and morphol-
ogy of the samples by X-ray powder diffraction (XRD) 
and scanning electron microscopy (SEM), respectively. In 
the case of doped samples we applied also energy disper-
sive X-ray spectroscopy (EDX) for elemental analysis. The 
efficient ion substitution process generates changes in the 
crystal structure compared to undoped HAP as Sr2+ has 
larger ionic radius (1.12 Å) than Ca2+ (0.99Å). Therefore, 
the lattice parameters and unit cell volume of the synthe-
tized products were determined as well.
Finally, we tested the antimicrobial properties of the 
Sr-doped HAPs namely in vitro cytotoxicity by colorimet-
ric reduction of INT (2-(4-Iodophenyl)-3-(4-nitrophenyl)-
5-phenyl-2H-tetrazolium chloride) against Escherichia 
coli bacterium strain.
2 Experimental
2.1 Preparation of pure and Sr-doped HAP
For the hydrothermal procedures calcium nitrate tetrahy-
drate [Ca(NO3)2∙4H2O, Sigma Aldrich] and diammonium 
hydrogen phosphate [(NH4)2HPO4, Sigma Aldrich] were dis-
solved in 50 ml ion exchanged water separately. After some 
minutes of stirring, 15 ml from the solutions were taken out 
and mixed together in a Teflon-lined autoclave (45 ml acid 
digestion vessel, Parr Ins.) which was followed by immedi-
ate white precipitate formation. Then we adjusted the pH by 
NH4OH (25 %, Molar Chemicals). For each hydrothermal 
treatment 180 °C was applied. Finally, the products were 
filtered and washed several times with ion exchanged water 
and ethanol and then dried at 60 °C for 2 hours.
We investigated the role of phosphate excess using a 
lower Ca/P molar ratio (1.49) besides the stoichiomet-
ric value (1.67, HAP1-2). Then, we studied the effect of 
solution pH and reaction time applying 9, 10, 11 and 12 
pH (HAP2-5) and 4, 8, 12 and 24 h (HAP2, HAP6-8), 
respectively, using Ca/P = 1.49 (Table 1).
In the case of Sr-doped HAP samples, specified 
amount of strontium nitrate [Sr(NO3)2, (Sigma Aldrich)] 
was added beside Ca(NO3)2 and then they were dissolved 
together. We used Sr in various Sr/(Ca+Sr) molar ratios 
(2/ 4/ 6/ 8/ 10 %, SrHAP2-10, Table 2). All the following 
reaction steps were the same as in the case of the above 
detailed synthesis.
2.2 Characterization
For XRD measurements a PANanalytical X’Pert Pro MPD 
diffractometer with Cu Kα radiation (λ = 0.15418 nm) 
was applied. For analyzing the morphology of HAP2-8 
a JEOL JSM 5500-LV, for HAP1 and Sr-doped samples 
(SrHAP2-10) a LEO 1540 XB electron microscope and 
for EDX measurements a JEOL JSM 5500-LV instrument 
were used. Lattice parameters were determined by least 
square refinements using the peak positions of the most 
intensive reflections [24].
Table 1 Preparation details the hydrothermally treated HAP samples
HAP1 HAP2 HAP3 HAP4 HAP5 HAP6 HAP7 HAP8
Ca(NO3)2∙4H2O (M) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
(NH4)2HPO4 (M) 0.60 0.67 0.67 0.67 0.67 0.67 0.67 0.60
Ca/P 1.67 1.49 1.49 1.49 1.49 1.49 1.49 1.49
time (h) 24 24 24 24 24 4 8 12
pH 11 11 9 10 12 10 10 10
Table 2 Preparation details the pure and Sr-doped HAP samples
SrHAP2 SrHAP4 SrHAP6 SrHAP8 SrHAP10
Ca(NO3)2∙4H2O (M) 0.98 0.96 0.94 0.92 0.90
(NH4)2HPO4 (M) 0.60 0.60 0.60 0.60 0.60
Sr(NO3)2 (M) 0.02 0.04 0.06 0.08 0.10
Sr/ (Ca+Sr) (mol%) 2 4 6 8 10
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2.3 Antimicrobial test
For revealing the antimicrobial properties, i.e. the cyto-
toxicity of the pure and Sr-doped HAP samples, we stud-
ied their effects on the cell viability of Escherichia coli 
(ATCC 25922) by tetrazolium reduction assay. The tetra-
zolium/formazan couple is a special redox system acting as 
proton acceptor or oxidant [25]. In the presence of bacteria, 
the tetrazolium salt (such as 2-(p-iodophenyl)-3(p-nitro-
phenyl)-5-phenyl tetrazolium chloride (INT)) is reduced 
to red formazan which is directly proportional to the via-
ble active cells. Therefore, the test method is considered as 
a comparatively fast method for evaluating the antibacte-
rial activity of antimicrobial agents.
The tests were carried out using direct contact method 
in shaken tubes filled with 10 ml Luria-Bertani Broth 
inoculated with 100-100 µL overnight E. coli suspension. 
HAP1 and SrHAP2-10 containing solutions were pre-
pared with the concentration of 3 mg/ml in 3-3 parallels. 
After 24 and 48 h incubation time we took 200 µL of each 
sample and pipetted it into the wells of a microtiter plate. 
30 µL of sterile INT solution was then added to the cells 
and the quantity of formazan was measured by recording 
changes in absorbance at 490 nm by a DIALAB ELx800 
microplate reader. All treatments were performed in five 
replicates. One-way analysis of variance (ANOVA) was 
performed and all p values less than 0.05 were consid-
ered statistically significant. To compare the treatments 
Fisher’s least significant difference test was carried out. 
3 Results and discussion
3.1 Effect of Ca/P ratio
With the utilization of different Ca/P ratios we exam-
ined the effect on the crystalline phases and crystallinity 
of the products. Based on the XRD patterns both HAP1 
(Ca/P = 1.67) and HAP2 (Ca/P = 1.49) samples were iden-
tified as pure HAP (ICDD 04-016-2958). Comparing their 
XRD patterns, we concluded that the P excess (lower 
Ca/P ratio) results improved crystallinity since HAP2 has 
sharper and narrower reflections (Fig. 1). Considering this 
result for investigating the role of applied pH and time we 
fixed the Ca/P at 1.49.
3.2 Effect of pH
All of the samples prepared at different pH values (9/ 10/ 
11/ 12) were pure HAP without any impurities (Fig. 2). 
According to the XRD patterns, pH does not have any role 
on the obtained crystalline phases of the products, however, 
it can influence the crystallinity. Increasing the pH from 9 
to 10 had favorable effect on the crystallization, however its 
further rising leads to lower crystallinity. As pH 10 induced 
the best crystallized samples compared to the others, we 
applied this value for studying the effect of reaction time.
According to the SEM images, samples prepared at 
pH 9 and 10 have mainly uniform morphology consti-
tuting of longer, needle-like shapes (Fig. 3). Most of the 
needles have 5-10 µm length and less than 1 µm width. 
At higher pH much shorter (1-5 µm), elongated crystals 
formed which were greatly agglomerated. Based on these 
images, for a well-defined morphology, the lower pH is 
more beneficial which is in good accordance with the 
results of the XRD measurements regarding the crystal-
linity of the samples.
Fig. 1 HAP samples prepared using different Ca/P ratios 
(180 °C, 24 h, pH = 11)
Fig. 2 XRD patterns of HAP samples prepared at different pH values 
(180 °C, 24 h, Ca/P = 1.49)
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3.3 Effect of reaction time
For examining the role of reaction time we applied 4/ 8/ 
12 and 24 h at 180 °C and pH 10. All XRD peaks were 
attributed to pure HAP phase in the case of every sample 
(Fig. 4). Although each sample had the same phase, their 
crystallinity increased with the employed time: the best 
crystallized phase was formed at 24 h, as it contains the 
most intensive and narrowest reflections. 
This is also confirmed by the SEM images (Fig. 5) which 
show that the longer reaction time facilitates the improve-
ment of morphology. During 12 h or less time many short, 
elongated shapes can be observed mainly on the surface of 
bigger particles with various sizes. Observably, there are 
no significant differences in the length or even width of 
the particles, however it changes greatly with 24 h reaction 
time. Instead of the initial elongated forms much longer 
(5-10 µm) and mostly individual rods are obtained.
3.4 Sr-doped HAPs
Sr doped samples were synthetized with various Sr 
amounts (2/ 4/ 6/ 8/ 10 %) at pH 11, 180 °C, 24 h. For com-
parison the Sr-doped samples to pure HAP we used HAP1 
as reference. All of the reflections of SrHAP2-10 were 
attributed to crystalline HAP phase (ICDD 04-016-2958, 
Fig. 6). The samples were well crystallized consisting of 
only narrow, sharp peaks without any other Sr-containing 
or amorphous phase.
The calculated lattice parameters and unit cell vol-
ume of the samples are in good accordance with the 
values found in the reference card (ICDD 04-016-2958, 
Table 3). The lattice constants of the hexagonal lattice 
increased due to the larger Sr2+ radius (1.12 Å) compared 
to Ca2+ (0.99 Å). Parameter a, b change from 9.4310 Å to 
9.4700 Å, c from 6.8819 Å to 6.9227 Å while the unit cell 
expands from 530.0951 Å3 to 537.6556 Å3.
Fig. 3 SEM images of HAP samples prepared at different pH values 
(180 °C, 24 h, Ca/P = 1.49)
Fig. 4 XRD patterns of HAP samples prepared at different time 
(180 °C, pH = 10, Ca/P = 1.49)
Fig. 5 SEM images of HAP samples prepared at different time 
(180 °C, pH = 10, Ca/P = 1.49)
Fig. 6 XRD patterns of pure and Sr-doped HAP samples prepared at 
different time (180 °C, 24 h, pH = 11, Ca/P = 1.67)
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The morphology of the HAP1, SrHAP2 and SrHAP4 is 
well defined and homogenous (Fig. 7). These samples con-
sist of ca. 100-150 nm long needles with 25-35 nm width 
in HAP1 and SrHAP2 and with 50 nm at SrHAP4. In the 
case of SrHAP6 both band-like and needle-like shapes are 
observed. The ribbons are ca. 100 nm wide and 200-300 
nm long while the needles have less than 50 nm width and 
100 nm length. Increasing Sr amount, however, facilitates 
the formation of needles causing uniform morphology in 
SrHAP8 and SrHAP10. SrHAP8 contains mostly needles 
with almost the same width and length (less than 50 nm) 
but they become bigger, namely 50-100 nm in width and 
100-200 nm in length in SrHAP10.
To study the elemental composition of the Sr-doped 
samples and confirm the presence of Sr, EDX was also 
carried out (Table 4). The main components of the samples 
were O, P, Ca, while Sr also could be detected in Sr-doped 
samples with increasing tendency.
3.5 Antibacterial test
For developing the in vitro cytotoxic effect of the pure 
and Sr-doped HAP samples, we performed INT reduction 
assay.
According to Fig. 8 every sample has obvious inhibit-
ing effect on the cell viability against E. coli after both 24 
and 48 h incubation time compared to HAP1. The higher 
absorbance means the greater number of viable bacteria. 
The strongest effect after 24 h belongs to SrHAP10 (~25 % 
inhibition compared to pure HAP) and even the tendency 
in the antibacterial activity along with increasing amount 
of Sr is observable (except SrHAP6). Statistically signif-
icant decrease (> 20 % inhibition) was found in the case 
of SrHAP2, SrHAP8 and SrHAP10 samples compared 
to pure HAP (Fig. 8) in the case of 48 h exposure time. 
However, SrHAP2 also presents as high antibacterial activ-
ity as SrHAP10. It is also seen, that SrHAP6 least suits the 
trend neither at 24 h nor at 48 h incubation time. Since the 
release of metal ion from the HAP structure has important 
role in the bactericidal effects among others, it is assumed 
that in the case of SrHAP6 it was not enough sufficient.
The results of this study agree with previous observa-
tions reported by Ravi et al. [18]. They also reported slight 
inhibition of Sr-substituted hydroxyapatite applied at 5 
and 10 % for E. coli.
4 Conclusion
We synthetized pure HAP samples by simple, one-step 
hydrothermal method. We examined the role of different 
Ca/P ratios, pH and time on the crystalline phases and the 
morphology as well. All the prepared samples were pure 
crystalline HAP, the changed parameters did not have 
effect the obtained crystalline phase. We found that lower, 
i.e. 1.49 Ca/P ratio resulted better-crystallized phase com-
pared to the stoichiometric 1.67 ratio. 9/ 10/ 11 and 12 pH 
values were used and pH 10 was considered to improve the 
crystallinity the greatest. The SEM images showed that at 
pH 9, 10 mostly uniform, needle-like shapes with 5-10 µm 
Table 4 EDX results of pure and Sr-doped HAP samples
O atom % P atom % Ca atom % Sr atom %
HAP1 59.7 15.4 24.9 -
SrHAP2 60.8 14.8 23.9 0.5
SrHAP4 61.8 14.5 22.8 0.9
SrHAP6 62.722 14.163 22.113 1.002
SrHAP8 64.306 13.874 20.395 1.424
SrHAP10 65.022 13.853 19.481 1.644
Table 3 Calculated lattice parameters of pure and Sr-doped HAP samples
a = b (Å) c (Å) V (Å3)
HAP1 9.4310 6.8819 530.0951
SrHAP2 9.4424 6.8928 532.2157
SrHAP4 9.4488 6.9017 533.6267
SrHAP6 9.4503 6.9063 534.1561
SrHAP8 9.4660 6.9159 536.6787
SrHAP10 9.4700 6.9227 537.6556
Fig. 7 SEM images of pure and Sr-doped HAP samples 
(180 °C, 24 h, pH = 11, Ca/P = 1.67)
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length and less than 1 µm width formed, while shorter 
(1-5 µm) needles grew at 11 and 12 pH. Increasing reaction 
time from 4 to 8, 12 and 24 h enhanced the crystallinity of 
the samples, however, their morphology changed remark-
ably only after 12 h. Till that time only short, elongated 
shapes greatly stuck to each other formed while at 24 h 
these shapes became longer (5-10 µm), individual needles. 
Sr-doped samples were identified also as HAP structures, 
although, the presence of Sr was detected by EDX in the 
case of all samples. The lattice constants a, b changed 
from 9.4310 Å to 9.4700 Å, c from 6.8819 Å to 6.9227 Å 
and the volume from 530.0951 Å3 to 537.6556Å3 due to the 
larger ionic radius of Sr compared to Ca. Every sample had 
mostly uniform morphology which changed a bit along 
with the greater amount of Sr. HAP1 and SrHAP2 consti-
tuted of 100-150 nm long needles with 25-35 nm width so 
did SrHAP4 but with 50 nm width. In the case of SrHAP6 
both 100 nm wide, 200-300 nm long bands and less than 
50 nm wide and 100 nm long needles formed. SrHAP8 
and SrHAP10 composed of needles which were less than 
50 nm long and wide but 50-100 nm in width and 100-200 
nm, respectively. In vitro cytotoxicity tests revealed obvi-
ous effective bactericidal properties in the case of doped 
samples compared to pure HAP against E. coli. Trend in 
decreasing absorbance due to the increasing amount of Sr 
was also observable in most cases.
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